Ahead, well explore why frozen shoulder happens around menopause, and how to deal with it
As shown in Scheme 3
According to The Menopause Society's 2022 Position Statement and the FDA's updated guidance, hormone therapy tends to carry its strongest benefit-to-risk profile for: Women who are under 60 years of age Women who are within 10 years of menopause onset Women who are experiencing moderate-to-severe vasomotor symptoms (hot flashes, night sweats) that significantly affect quality of life Women who don't have contraindications including certain cardiovascular conditions, active or history of certain hormone-sensitive cancers, active blood clots, or liver disease An online HRT platform like Gala is most likely a good fit for women who: Have a relatively straightforward symptom presentation without complex medical comorbidities that require in-person evaluation Have found traditional care settings inaccessible, expensive, or inadequate for menopause-specific concerns Value convenience, no-insurance-required access, and delivery-to-door logistics Are in an early-menopause timing window where the evidence profile for HRT is most favorable Are comfortable with a provider relationship conducted entirely online and understand the limitations of telehealth versus in-person care It's a less natural fit for women with complex medical histories, active cardiovascular concerns, or situations that need a physical exam, imaging, or in-person labs that a telehealth workflow can't accommodate
Step 2: Reauthorization for Wegovy UnitedHealthcare may approve reauthorization and cover Wegovy for an additional 12 months after initial authorization if you meet two conditions: You must have lost at least 5% of your body weight during your first four months of taking Wegovy
Get Adequate Sleep Sleep deprivation increases cortisol production, leading to increased cravings and emotional eating
